Bonesupport Holding ABBOEUF 81 EBIT per Share is $0.44 as of Mar. 2026. GuruFocus rates BOEUF with a GF Score™ of 81/100 and a GF Value™ of $42.59 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 690 Medical Devices & Instruments companies, Bonesupport Holding AB ranks worse than 144927.39% on this metric.
Bonesupport Holding AB's EBIT per Share for the
three
months ended in Mar. 2026 was $0.12.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.44.
During the past 12 months, the average EBIT per Share Growth Rate of Bonesupport Holding AB was 67.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Bonesupport Holding AB's EBIT per Share or its related term are showing as below:
During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Bonesupport Holding AB was 29.90% per year. The lowest was -43.20% per year. And the median was -1.70% per year.
BOEUF's 3-Year EBIT Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.6 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Bonesupport Holding AB (OTCPK:BOEUF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Bonesupport Holding AB EBIT per Share Related Terms
Bonesupport Holding AB EBIT per Share Historical Data
* Premium members only.
The historical data trend for Bonesupport Holding AB's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonesupport Holding AB (BOEUF) has a EBIT per Share of $0.44 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bonesupport Holding AB and its competitors. According to the industry distribution chart, Bonesupport Holding AB ranks #999999 out of 690 companies in the Medical Devices & Instruments industry.
Is Bonesupport Holding AB's EBIT per Share too high?
Bonesupport Holding AB's current EBIT per Share is $0.44. The Medical Devices & Instruments industry median EBIT per Share is 9.60. Bonesupport Holding AB's value of $0.44 is 95.4% below this industry median. Based on the distribution chart, Bonesupport Holding AB ranks #999999 out of 690 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bonesupport Holding AB has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonesupport Holding AB ranks #999999 out of 690 companies for EBIT per Share. This places Bonesupport Holding AB in the lower half of its industry. The industry median EBIT per Share is 9.60. Bonesupport Holding AB's value of $0.44 is 95.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonesupport Holding AB's current EBIT per Share of $0.44 is 95.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bonesupport Holding AB and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonesupport Holding AB's current EBIT per Share is $0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (BOEUF) is currently considered Significantly Undervalued. The stock's GF Value™ is $42.59, compared to a current price of $21.40 — trading 49.8% below its estimated fair value. The current EBIT per Share is $0.44 and 95.4% below the Medical Devices & Instruments industry median of 9.60. Bonesupport Holding AB's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Bonesupport Holding AB (BOEUF), the current EBIT per Share is $0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonesupport Holding AB (BOEUF) Overvalued in 2026?
Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued.
The current stock price of $21.40 is trading 49.8% below its estimated GF Value™ of $42.59.
GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.
Key valuation signals for BOEUF:
EBIT per Share: $0.44
GF Value™: $42.59 vs. price of $21.40 (49.8% below fair value)
Industry Position: 95.4% below the Medical Devices & Instruments median (#999999 of 690)
No single metric tells the full story. See the BOEUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
81GF Score
Get the complete analysis for BOEUF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOEUF has been successfully added to your 
